未登录

D

Dennis Bourdette

oregon health & science university

H指数:67

被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Implementation of a pilot online educational program to identify paramagnetic rim lesions

实施一项试点在线教育计划以识别顺磁性边缘病灶

Multiple Sclerosis Journal

IF5

2026-08-220

PRE

Stop the Spin: Confronting Reporting Bias in Multiple Sclerosis Research

Annals of Neurology

IF7.7

2026-01-260

PRE

Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare Program

NEUROLOGY-CLINICAL PRACTICE

IF3.2

2025-02-010

PRE

Investigating When Patients With Multiple Sclerosis Should Switch From a Low- or Moderate-Efficacy Therapy to a High-Efficacy Treatment

IF8.5

2024-09-240

PRE

Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?

NEUROTHERAPEUTICS

IF6.9

2024-07-010

OAAI

The Challenges of Treating Late-Onset Multiple Sclerosis

IF8.5

2024-03-260

PRE

Rituximab for Multiple Sclerosis Hiding in Plain Sight

IF8.5

2024-01-233

OAAI

What Are the Risks of Guillain-Barré Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination?

IF8.5

2023-11-142

PRE

Polypharmacy in multiple sclerosis: More is not necessarily better

MULTIPLE SCLEROSIS JOURNAL

IF5

2022-10-145

PRE

Better Patient Outcomes at Less Cost: An Effective Strategy for Neurology Care

ANNALS OF NEUROLOGY

IF7.7

2022-06-110

PRE

Accelerating Clinical Trials of New Therapies for Progressive Multiple Sclerosis Thinking Anew

IF8.5

2022-05-030

PRE

Association Between Pharmacy Benefit Restrictions and Disease-Modifying Therapy Use in the Medicare Part D Program

NEUROLOGY-CLINICAL PRACTICE

IF3.2

2022-02-010

OA

TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor

CELL CHEMICAL BIOLOGY

IF7.2

2022-02-0115

OAAI

Longer-term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis

IF8.5

2021-10-190

PRE

Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis Drugs

NEUROLOGY-CLINICAL PRACTICE

IF3.2

2021-08-018

OA

Quelling Public Fears About Guillain-Barre Syndrome and COVID-19 Vaccination

IF8.5

2021-06-017

PRE

Myelin-specific T cells in animals with Japanese macaque encephalomyelitis

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY

IF3.9

2021-01-136

OA

Two decades of research Time to incorporate comorbidity management into the care of MS?

IF8.5

2020-08-041

PRE

Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

IF8.5

2020-06-02140

PREAI

Effect of generic glatiramer acetate on spending and use of drugs for multiple sclerosis

IF8.5

2020-03-3112

PREAI